Loss of PTPN12 Stimulates Progression of ErbB2-Dependent Breast Cancer by Enhancing Cell Survival, Migration, and Epithelial-to-Mesenchymal Transition
暂无分享,去创建一个
Morag Park | W. Muller | Morag Park | Juan Li | Ning Wu | A. Veillette | William J. Muller | André Veillette | Juan Li | Dominique Davidson | Cleiton Martins Souza | Ming-Chao Zhong | Ning Wu | Ming-Chao Zhong | Dominique Davidson | Cleiton Martins Souza
[1] E. Giannoni,et al. Anoikis: an emerging hallmark in health and diseases , 2012, The Journal of pathology.
[2] S. Latour,et al. EAT-2, a SAP-like adaptor, controls NK cell activation through phospholipase Cγ, Ca++, and Erk, leading to granule polarization , 2014, The Journal of experimental medicine.
[3] M. Tremblay,et al. Protein Tyrosine Phosphatase-PEST Regulates Focal Adhesion Disassembly, Migration, and Cytokinesis in Fibroblasts , 1999, The Journal of cell biology.
[4] M. Rao,et al. Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase , 2011, Cell.
[5] H. Tian,et al. PTPN12 inhibits oral squamous epithelial carcinoma cell proliferation and invasion and can be used as a prognostic marker , 2013, Medical Oncology.
[6] Tony Pawson,et al. Temporal regulation of EGF signaling networks by the scaffold protein Shc1 , 2013, Nature.
[7] J. Yun,et al. The prognostic significance of tyrosine-protein phosphatase nonreceptor type 12 expression in nasopharyngeal carcinoma , 2015, Tumor Biology.
[8] J Wagner,et al. Phosphotyrosine-independent Binding of SHC to the NPLH Sequence of Murine Protein-tyrosine Phosphatase-PEST , 1996, The Journal of Biological Chemistry.
[9] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] Inmoo Rhee,et al. The phosphatase PTP-PEST promotes secondary T cell responses by dephosphorylating the protein tyrosine kinase Pyk2. , 2010, Immunity.
[11] Dana M. Brantley-Sieders,et al. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. , 2008, The Journal of clinical investigation.
[12] Inmoo Rhee,et al. Control of Dendritic Cell Migration, T Cell-Dependent Immunity, and Autoimmunity by Protein Tyrosine Phosphatase PTPN12 Expressed in Dendritic Cells , 2013, Molecular and Cellular Biology.
[13] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[14] R. Cardiff,et al. PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis* , 2009, The Journal of Biological Chemistry.
[15] Michael D Schaller,et al. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions , 2010, Journal of Cell Science.
[16] S. Hardy,et al. Inside the human cancer tyrosine phosphatome , 2010, Nature Reviews Cancer.
[17] W. Muller,et al. Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis , 2011, Proceedings of the National Academy of Sciences.
[18] E. Pasquale,et al. NSP-CAS Protein Complexes: Emerging Signaling Modules in Cancer. , 2012, Genes & cancer.
[19] Xunyi Yuan,et al. Clinicopathological significance of PTPN12 expression in human breast cancer , 2012, Brazilian Journal of Medical and Biological Research.
[20] M. Tremblay,et al. Essential function of PTP-PEST during mouse embryonic vascularization, mesenchyme formation, neurogenesis and early liver development , 2006, Mechanisms of Development.
[21] P. Defilippi,et al. Cas proteins: dodgy scaffolding in breast cancer , 2014, Breast Cancer Research.
[22] Jia Fu,et al. Decreased Expression of PTPN12 Correlates with Tumor Recurrence and Poor Survival of Patients with Hepatocellular Carcinoma , 2014, PloS one.
[23] A. Veillette,et al. PTP‐PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates , 2001, The EMBO journal.
[24] V. Paralkar,et al. Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis , 2007, Proceedings of the National Academy of Sciences.
[25] J. Vacher,et al. Macrophage Fusion Is Controlled by the Cytoplasmic Protein Tyrosine Phosphatase PTP-PEST/PTPN12 , 2013, Molecular and Cellular Biology.
[26] G Melino,et al. PTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling , 2014, Oncogene.
[27] Z. Wen,et al. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer , 2015, Oncotarget.
[28] J. Gratton,et al. The Phosphatase PTP-PEST/PTPN12 Regulates Endothelial Cell Migration and Adhesion, but Not Permeability, and Controls Vascular Development and Embryonic Viability* , 2012, The Journal of Biological Chemistry.
[29] M. Tremblay,et al. Combination of gene targeting and substrate trapping to identify substrates of protein tyrosine phosphatases using PTP-PEST as a model. , 1998, Biochemistry.
[30] N. Tonks,et al. Protein tyrosine phosphatases: from genes, to function, to disease , 2006, Nature Reviews Molecular Cell Biology.
[31] Gema Moreno-Bueno,et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.
[32] Samy Lamouille,et al. Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.
[33] K. Siminovitch,et al. Nonreceptor protein-tyrosine phosphatases in immune cell signaling. , 2007, Annual review of immunology.
[34] Francesca Orso,et al. p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells , 2012, Breast Cancer Research.
[35] Qidong Ge,et al. Low expression of tyrosine-protein phosphatase nonreceptor type 12 is associated with lymph node metastasis and poor prognosis in operable triple-negative breast cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[36] T. Pawson,et al. ShcA signalling is essential for tumour progression in mouse models of human breast cancer , 2008, The EMBO journal.
[37] Michael A. Bookman,et al. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56 lck , 1988, Cell.
[38] C. M. Souza,et al. PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders , 2009, Immunological reviews.